Quality of Anticoagulation With Vitamin K Antagonists-Reference-Cited by-同舟云学术

Quality of Anticoagulation With Vitamin K Antagonists

Published:2015-05-11 Issue:6 Volume:38 Page:357-364
ISSN:0160-9289
Container-title:Clinical Cardiology
language:en
Short-container-title:Clin Cardiol

Author:

Bertomeu-González Vicente¹,Anguita Manuel²³,Moreno-Arribas José¹,Cequier Ángel²⁴,Muñiz Javier⁵,Castillo-Castillo Jesús¹,Sanchis Juan⁶,Roldán Inmaculada⁷,Marin Francisco⁸,Bertomeu-Martínez Vicente¹²,

Affiliation:

1. Department of Cardiology; San Juan University Hospital, Miguel Hernández University; Alicante Spain

2. Department of Cardiology; Research Agency of the Spanish Society of Cardiology; Madrid Spain

3. Department of Cardiology; University Hospital Reina Sofía; Córdoba Spain

4. Department of Cardiology; Bellvitge University Hospital, L'Hospitalet de Llobregat; Barcelona Spain

5. Department of Cardiology; University Institute in Health Sciences, University of A Coruña, A Coruña Biomedical Research Institute; A Coruña Spain

6. Department of Cardiology; Hospital Clinic of València, University of Valencia; Valencia Spain

7. Department of Cardiology; University Hospital La Paz; Madrid Spain

8. Department of Cardiology; University Hospital Virgen de la Arrixaca; Murcia Spain

Funder

Bristol-Myers Squibb

Pfizer

Instituto de Salud Carlos III

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/clc.22397/fullpdf

Reference23 articles.

1. Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients;Wilke;Eur Soc Cardiol,2013

2. Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression;Mearns;Thromb J.,2014

3. Effect of study setting on anticoagulation control: a systematic review and meta-regression;Walraven;Chest.,2006

4. Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review;Wan;Circ Cardiovasc Qual Outcomes.,2008

5. Meta-analysis to assess the quality of warfarin control in atrial fibrillation patients in the United States;Baker;J Manag Care Pharm.,2009

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Situación actual de los anticoagulantes orales de acción directa en atención primaria de España. Posicionamiento de SEMERGEN en 2023;Medicina de Familia. SEMERGEN;2024-04

2. Characteristics and management of patients with stroke and major hemorrhagic episodes with atrial fibrillation under vitamin K antagonist therapy. EVENTHO study;Medicina Clínica;2022-10

3. Characteristics and management of patients with stroke and major hemorrhagic episodes with atrial fibrillation under vitamin K antagonist therapy. EVENTHO study;Medicina Clínica (English Edition);2022-10

4. A comparison of front-line oral anticoagulants for the treatment of non-valvular atrial fibrillation: effectiveness and safety of direct oral anticoagulants in the FANTASIIA registry;Expert Opinion on Pharmacotherapy;2022-08-12

5. Incidence of left atrial appendage thrombus despite 3 weeks of anticoagulation and the need for precardioversion echocardiography;Annals of Noninvasive Electrocardiology;2022-07-08